Table 3

Hs-CRP, SAA and fasting lipids

Healthy controls
Median (range)
All patients with KD
Median (range)
KD vs controls
p Value (95% CI of diff)
KD CAA−
Median (range)
CAA− vs controls
p Value (95% CI of diff)
KD CAA+
Median (range)
CAA+ vs controls
p Value (95% CI of diff)
p Value (Kruskal–Wallis)*
Hs-CRP (mg/L)0.25 (0.00, 69.40)
(n=49)
0.47 (0.01, 84.98)
(n=89)
p=0.25 (−0.05 to 0.29)0.46 (0.01, 11.16)
(n=52)
p=0.30 (−0.07 to 0.28)0.60 (0.02, 84.98)
(n=37)
p=0.35 (−0.08 to 0.44)0.51
SAA (mg/L)0.80 (0.08, 14.71)
(n=49)
1.21 (0.07, 225.2)
(n=89)
p=0.22 (−0.11 to 0.62)1.28 (0.07, 46.00)
(n=52)
p=0.35 (−0.19 to 0.67)1.19 (0.13, 225.2)
(n=37)
p=0.23 (−0.13 to 0.74)0.44
Total cholesterol (mmol/L)4.40 (2.70, 5.90)
(n=47)
4.15 (2.50, 6.70)
(n=84)
p=0.44 (−0.4 to 0.2)4.30 (2.50, 6.70)
(n=49)
p=0.93 (−0.30 to 0.30)4.00 (2.60, 5.50)
(n=35)
p=0.16 (−0.6 to 0.1)0.25
LDL (mmol/L)2.27 (0.70, 4.34)
(n=47)
2.28 (0.93, 4.90)
(n=84)
p=1.00 (−0.26 to 0.24)2.46 (1.04, 4.90)
(n=48)
p=0.51 (−0.2 to 0.4)2.25 (0.93, 3.66)
(n=35)
p=0.41 (−0.44 to 0.15)0.30
HDL (mmol/L)1.40 (0.40, 2.40)
(n=47)
1.40 (0.70, 2.10)
(n=83)
p=0.37 (−0.2 to 0.1)1.40 (0.70, 2.10)
(n=48)
p=0.38 (−0.2 to 0.1)1.40 (0.90, 2.00)
(n=35)
p=0.52 (−0.2 to 0.1)0.65
TG (mmol/L)0.77 (0.39, 3.34)
(n=47)
0.81 (0.34, 2.66)
(n=84)
p=0.74 (−0.09 to 0.14)p=0.81 (0.43, 2.66)
(n=49)
p=0.78 (−0.1 to 0.16)p=0.81 (0.34, 1.57)
(n=35)
p=0.77 (−0.12 to 0.16)0.94
  • All values are median (range) unless otherwise specified. Number (n) of subjects in each group as specified per test due to missing data points.

  • *p Values from Kruskal–Wallis test comparing three groups: controls, CAA− and CAA+. 95% CI of diff, 95% CI of the difference of median.

  • CAA, coronary artery aneurysms; HDL, high-density lipoprotein; hs-CRP, high-sensitivity C reactive protein; KD, Kawasaki disease; LDL, low-density lipoprotein; SAA, serum amyloid A; TG, triglycerides.